Your browser doesn't support javascript.
loading
Added value of enhanced CT on LR-3 and LR-4 observation of Gd-EOB-DTPA MRI for the diagnosis of HCC: are CT and MR washout features interchangeable?
Lim, Kyungjae; Kwon, Heejin; Cho, Jinhan; Kim, Dongwon; Kang, Eunju; Kim, Sanghyeon.
Afiliação
  • Lim K; Department of Radiology, Dong-A university Hospital, Dongdaesindong 3ga, Seo-gu, Pusan, South Korea.
  • Kwon H; Department of Radiology, Dong-A university Hospital, Dongdaesindong 3ga, Seo-gu, Pusan, South Korea.
  • Cho J; Department of Radiology, Dong-A university Hospital, Dongdaesindong 3ga, Seo-gu, Pusan, South Korea.
  • Kim D; Department of Radiology, Dong-A university Hospital, Dongdaesindong 3ga, Seo-gu, Pusan, South Korea.
  • Kang E; Department of Radiology, Dong-A university Hospital, Dongdaesindong 3ga, Seo-gu, Pusan, South Korea.
  • Kim S; Department of Radiology, Dong-A university Hospital, Dongdaesindong 3ga, Seo-gu, Pusan, South Korea.
Br J Radiol ; 95(1132): 20210738, 2022 Apr 01.
Article em En | MEDLINE | ID: mdl-34928175
ABSTRACT

OBJECTIVE:

To characterize the use of portal venous or delayed phase CT as an alternative to estimate washout for the non-invasive diagnosis of hepatocellular carcinoma (HCC) on gadoxetic acid-enhanced MRI in combination with other features.

METHODS:

This retrospective study included 226 observations (n = 162 patients) at high risk for HCC imaged with gadoxetic acid-enhanced MRI and enhanced liver CT between March 2015 and March 2018. Two radiologists independently evaluated two sets of images and assigned the final Liver Imaging Reporting and Data System (LI-RADS) categories by consensus using gadoxetic acid-enhanced MRI. LR-1, LR-2, LR-5, and LR-M were excluded from the study.The observations were divided using different criteria for washout hypointensity on the portal venous phase (PVP) at MRI (criteria 1), hypointensity on PVP at MRI and/or hypoattenuation on the PVP/delayed phase at dynamic CT (criteria 2), and hypointensity on the PVP and/or hepatobiliary phase at MRI (criteria 3). The sensitivity, specificity, and accuracy for the diagnosis of HCC were analyzed for each criterion.

RESULTS:

Using gadoxetic acid-enhanced, 226 lesions were diagnosed as LR-3 or LR-4 by LI-RADS. Among them, 98 and 152 had "washout" at criteria 1 and 2, respectively. For the diagnosis of HCC, criteria 2 and 3 showed significantly higher sensitivities (67.3 and 92.5%, respectively) compared with criteria 1 (35.5%) (p < 0.001). The specificity of criteria 3 (13%) was significantly lower than those of criteria 1 and 2 (40.7% and 38.4%, respectively, p < 0.001). The specificities between criteria 1 and 2 were not statistically different (p = 0.427).

CONCLUSION:

Although the LI-RADS lexicon does not permit the interchange of image features among various image modalities, the sensitivity of HCC diagnosis could be improved without any decrease in specificity by adding CT image washout features. ADVANCES IN KNOWLEDGE Although the LI-RADS lexicon does not permit the interchange of image features among various image modalities, complementary use of dynamic CT in LR-3 or LR-4 categories on the basis of gadoxetic acid-enhanced MRI may contribute to major imaging feature.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article